Events
PharmaMar (MSE:PHM) presented new data on lurbinectedin during the World Conference on Lung Cancer (WCLC), which is taking place from 7th to 10th September in Barcelona.
Amgen announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors.
MaxCyte announces that Director of Field Applications Scientists Christopher Mann, PhD, will present on “Advancing Adoptive Cellular Therapies Using Non-viral-based Engineering” at the 2nd International Conference on Lymphocyte Engineering on Saturday 14 September at 9:50 a.m. BST.
BerGenBio ASA presents study updates from its Phase II clinical development programme with bemcentinib, a first-in-class highly selective oral AXL inhibitor, in non-small cell lung cancer at the 2019 World Conference on Lung Cancer in Barcelona, Spain.
Rho, a full-service contract research organization, is showcasing its nearly 35-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials Texas 2019 Conference, the newest addition to the Outsourcing in Clinical Trials series, taking place September 11-12 in Houston.
Martinsried/ Munich Medigene AG announced its participation at the following upcoming scientific and investor conferences.
Jett Foundation, a non-profit organization dedicated to raising awareness and funds for Duchenne muscular dystrophy, will celebrate World Duchenne Awareness Day (WDAD) on Saturday, September 7.
The Therapeutic Antibody Revolution in the Post Genomics Era: Using High Throughput SPR to Explore the Full Kinetic and Epitope Diversity of Antibody Libraries Supporting mAb, CAR-T, Bispecifics and ADC Therapeutic Discovery
Summit Therapeutics plc presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in animal models of sepsis, pneumonia and urinary tract infection.
Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living celebrates 150 years of fermentation and biotechnology expertise and innovation at its site in Delft, the Netherlands.
PRESS RELEASES